Publications by authors named "Franck Priou"

Claim this Profile
H
Home-based supervised exercise on metastatic cancer patients receiving oral targeted therapy: the AFSOS-Unicancer QUALIOR randomized phase 2 study.
Florence Joly, Claudia Lefeuvre-Plesse, Emilie Charton, Carole Helissey, Franck Priou

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA.
Emeline Colomba, Sarah Flora Jonas, Jean-Christophe Eymard, Rémi Delva, Pierre Emmanuel Brachet, Franck Priou

Eur Urol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
Eric Voog, Boris Campillo-Gimenez, Claude Elkouri, Franck Priou, Frederic Rolland

Int J Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to 'Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma' [Eur J Cancer 108 (February 2019) 33-40].
Marie Auvray, Edouard Auclin, Philippe Barthelemy, Petri Bono, Pirkko Kellokumpu-Lehtinen, Franck Priou

Eur J Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.
Stéphane Oudard, Igor Latorzeff, Armelle Caty, Laurent Miglianico, Emmanuel Sevin, Franck Priou

JAMA Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma.
Marie Auvray, Edouard Auclin, Philippe Barthelemy, Petri Bono, Pirkko Kellokumpu-Lehtinen, Franck Priou

Eur J Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study.
Emeline Colomba, Gwénaël Le Teuff, Tim Eisen, Grant D Stewart, Kate Fife, Franck Priou

Eur J Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial.
Gwenaelle Gravis, Jean-Marie Boher, Florence Joly, Michel Soulié, Laurence Albiges, Franck Priou

Eur Urol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
Gwenaelle Gravis, Jean-Marie Boher, Karim Fizazi, Florence Joly, Franck Priou

Eur Urol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2.
Stéphane Oudard, Stéphane Culine, Yann Vano, François Goldwasser, Christine Théodore, Franck Priou

Eur J Cancer· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15).
Gwenaelle Gravis, Patricia Marino, Florence Joly, Stéphane Oudard, Franck Priou

Eur J Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.
Gwenaelle Gravis, Karim Fizazi, Florence Joly, Stéphane Oudard, Franck Priou

Lancet Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study.
Stéphane Oudard, Eugeniu Banu, Annick Vieillefond, Laure Fournier, Franck Priou

J Urol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis